Cargando…

Correlation of PK/PD Indices with Resistance Selection for Cefquinome against Staphylococcus aureus in an In Vitro Model

Cefquinome is a fourth-generation Cephalosporin approved for use in animals exclusively. The objective of this study was to explore the relationship of cefquinome pharmacokinetic/pharmacodynamic (PK/PD) indices with resistance selection of Staphylococcus aureus ATCC25923 in an in vitro model. Six do...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Yafei, Feng, Baoyi, Gu, Xiaoyan, Yang, Dawei, Zeng, Zhenling, Zhang, Bingxu, Ding, Huanzhong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2016
Materias:	Microbiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4828644/ http://dx.doi.org/10.3389/fmicb.2016.00466

Ejemplares similares

Relationship between Cefquinome PK/PD Parameters and Emergence of Resistance of Staphylococcus aureus in Rabbit Tissue-Cage Infection Model
por: Xiong, Mingpeng, et al.
Publicado: (2016)

Integration of PK/PD for dose optimization of Cefquinome against Staphylococcus aureus causing septicemia in cattle
por: Ahmad, Ijaz, et al.
Publicado: (2015)

The PK/PD Interactions of Doxycycline against Mycoplasma gallisepticum
por: Zhang, Nan, et al.
Publicado: (2016)

Kill Rate and Evaluation of Ex Vivo PK/PD Integration of Cefquinome Against Actinobacillus pleuropneumoniae
por: Zhang, Longfei, et al.
Publicado: (2021)

In vivo evaluation of mutant selection window of cefquinome against Escherichia coli in piglet tissue-cage model
por: Zhang, Bingxu, et al.
Publicado: (2014)

PK-PD integration of enrofloxacin and cefquinome alone and in combination against Klebsiella pneumoniae using an in vitro dynamic model
por: Wei, Yanzhe, et al.
Publicado: (2023)

Pharmacokinetic/Pharmacodynamic Correlation of Cefquinome Against Experimental Catheter-Associated Biofilm Infection Due to Staphylococcus aureus
por: Zhou, Yu-Feng, et al.
Publicado: (2016)

Dose Assessment of Cefquinome by Pharmacokinetic/Pharmacodynamic Modeling in Mouse Model of Staphylococcus aureus Mastitis
por: Yu, Yang, et al.
Publicado: (2016)

In vitro dynamic pharmacokinetic/pharmacodynamic(PK/PD) modeling and PK/PD cutoff of cefquinome against Haemophilus parasuis
por: Xiao, Xia, et al.
Publicado: (2015)

In vitro susceptibility of four antimicrobials against Riemerella anatipestifer isolates: a comparison of minimum inhibitory concentrations and mutant prevention concentrations for ceftiofur, cefquinome, florfenicol, and tilmicosin
por: Li, Yafei, et al.
Publicado: (2016)

Murine Thigh Microdialysis to Evaluate the Pharmacokinetic/Pharmacodynamic Integration of Cefquinome Against Actinobacillus pleuropneumoniae
por: Zhang, Longfei, et al.
Publicado: (2020)

Histidine Metabolism and IGPD Play a Key Role in Cefquinome Inhibiting Biofilm Formation of Staphylococcus xylosus
por: Zhou, Yong-hui, et al.
Publicado: (2018)

The PK–PD Relationship and Resistance Development of Danofloxacin against Mycoplasma gallisepticum in An In Vivo Infection Model
por: Zhang, Nan, et al.
Publicado: (2017)

The PK/PD Integration and Resistance of Tilmicosin against Mycoplasma hyopneumoniae
por: Huang, Zilong, et al.
Publicado: (2020)

Microdialysis Determination of Cefquinome Pharmacokinetics in Murine Thigh From Healthy, Neutropenic, and Actinobacillus pleuropneumoniae-Infected Mice
por: Zhang, Longfei, et al.
Publicado: (2019)

Response of a clinical Escherichia coli strain to repeated cefquinome exposure in a piglet tissue-cage model
por: Gu, Mengxiao, et al.
Publicado: (2015)

Development of Stability-Indicating Methods for Cefquinome Sulphate
por: Shantier, Shaza W., et al.
Publicado: (2013)

In Vivo Pharmacokinetics/Pharmacodynamics of Cefquinome in an Experimental Mouse Model of Staphylococcus Aureus Mastitis following Intramammary Infusion
por: Yu, Yang, et al.
Publicado: (2016)

In vivo Pharmacokinetic and Pharmacodynamic (PK/PD) Modeling and Establishment of the PK/PD Cutoff of Florfenicol Against Pasteurella multocida in Ducks
por: Xiao, Xia, et al.
Publicado: (2021)

Isopropoxy Benzene Guanidine Kills Staphylococcus aureus Without Detectable Resistance
por: Zhang, Xiufeng, et al.
Publicado: (2021)

Pharmacokinetics and Pharmacodynamics (PK/PD) of Corallopyronin A against Methicillin-Resistant Staphylococcus aureus
por: Rox, Katharina, et al.
Publicado: (2022)

PK/PD integration of florfenicol alone and in combination with doxycycline against Riemerella anatipestifer
por: Zhang, Huilin, et al.
Publicado: (2022)

Ex Vivo Pharmacokinetics and Pharmacodynamics Modeling and Optimal Regimens Evaluation of Cefquinome Against Bovine Mastitis Caused by Staphylococcus aureus
por: Jiang, Li-jie, et al.
Publicado: (2022)

PK/PD Modeling to Assess Rifaximin Clinical Dosage in a Mouse Model of Staphylococcus aureus-Induced Mastitis
por: Wang, Honglei, et al.
Publicado: (2021)

Efficacy of Cefquinome against Escherichia coli Environmental Mastitis Assessed by Pharmacokinetic and Pharmacodynamic Integration in Lactating Mouse Model
por: Yu, Yang, et al.
Publicado: (2017)

Efficacy of Antimicrobial Peptide DP7, Designed by Machine-Learning Method, Against Methicillin-Resistant Staphylococcus aureus
por: Zhang, Rui, et al.
Publicado: (2019)

Pharmacokinetic/Pharmacodynamic (PK/PD) Evaluation of Dalbavancin Alone and in Combination with Ceftaroline against Methicillin-Resistant Strains (MRSA) of Staphylococcus aureus
por: Kebriaei, Razieh, et al.
Publicado: (2017)

Paeoniflorin Derivative in Paeoniae Radix Aqueous Extract Suppresses Alpha-Toxin of Staphylococcus aureus
por: Liu, Xiaoye, et al.
Publicado: (2021)

Oseltamivir PK/PD Modeling and Simulation to Evaluate Treatment Strategies against Influenza-Pneumococcus Coinfection
por: Boianelli, Alessandro, et al.
Publicado: (2016)

Emergence and Mechanism of Resistance of Tulathromycin Against Mycoplasma hyopneumoniae in a PK/PD Model and the Fitness Costs of 23S rRNA Mutants
por: Xia, Xirui, et al.
Publicado: (2022)

Relationship between danofloxacin PK/PD parameters and emergence and mechanism of resistance of Mycoplasma gallisepticum in In Vitro model
por: Zhang, Nan, et al.
Publicado: (2018)

Prevalence of Staphylococcus aureus and Methicillin-Resistant Staphylococcus aureus in Retail Ready-to-Eat Foods in China
por: Yang, Xiaojuan, et al.
Publicado: (2016)

2531. Pharmacokinetic-Pharmacodynamic (PK-PD) Target Attainment Analyses to Support Ceftobiprole Dosing Regimens for Patients with Staphylococcus aureus Bacteremia (SAB)
por: Bhavnani, Sujata M, et al.
Publicado: (2023)

Non-antibiotic strategies for prevention and treatment of internalized Staphylococcus aureus
por: Li, Jiangbi, et al.
Publicado: (2022)

Traditional PK-PD Indices for Efficacy – Can We Do Better?
por: Lakota, Elizabeth A, et al.
Publicado: (2017)

Panton-Valentine Leucocidin (PVL) as a Potential Indicator for Prevalence, Duration, and Severity of Staphylococcus aureus Osteomyelitis
por: Jiang, Bei, et al.
Publicado: (2017)

Staphylococcus aureus lipoproteins in infectious diseases
por: Mohammad, Majd, et al.
Publicado: (2022)

Stability of Ceftiofur Sodium and Cefquinome Sulphate in Intravenous Solutions
por: Dołhań, Agnieszka, et al.
Publicado: (2014)

Preparation of Cefquinome Sulfate Proliposome and its Pharmacokinetics in Rabbit
por: FU, Qiang, et al.
Publicado: (2013)

Role of sodium pyruvate in maintaining the survival and cytotoxicity of Staphylococcus aureus under high glucose conditions
por: Chen, Ti, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_etdp8agvtbti5ifl8fthbpiljb